Delivery Order SPE2DB25D7068-SPE2DB26FTVAX
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cetirizine HCL 5 mg tablets (100-count units) on September 10, 2025, with a ceiling value of $4,911.62 and ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $14,394.77 for 500 tablets of Cetirizine HCL 10 mg on September 25, 2025, with completion scheduled for September 26, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Cetirizine HCL 5 mg tablets (100-count packages) with a ceiling value of $7,861.18. This firm fixed price delivery order, with an ultimate completion date of September 17, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The contract was awarded on a competitive basis with no set-aside designation and will be performed at...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on August 14, 2025, for Cetirizine HCL 10 mg tablets (100-count) with a ceiling value of $1,088.45. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 15, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive role as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Cetirizine HCL 5 mg tablets (100-count units) with a ceiling value of $12,853.67. This firm fixed-price delivery order, set to conclude by September 15, 2025, represents a routine pharmaceutical procurement to support federal medical supply requirements. The contract is non-set-aside and was competitively awarded, reflecting AmerisourceBergen's established capability as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,078.62 to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 5 mg tablets (100 count) with a completion date of November 3, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cetirizine HCL 5 mg tablets (100-count) valued at $12,245.13 under a firm fixed price arrangement. The award, issued September 5, 2025, with completion expected by September 8, 2025, represents a non-competitive delivery order against an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Cetirizine HCL 10 mg tablets in quantities of 500 units. This firm fixed-price delivery order, valued at $2,119.84, represents a non-competitive set-aside award and carries a completion deadline of August 22, 2025. The pharmaceutical products will be sourced from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates as a...
- The Defense Logistics Agency awarded a delivery order valued at $2,284.65 to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 5 mg tablets (100-count packages) on July 14, 2025, with completion targeted for July 15, 2025. This firm fixed-price, competitively awarded delivery order carries no set-aside designation and represents a continuation of the contractor's role as a critical pharmaceutical supplier to federal healthcare systems. The place of performance is listed as...
- The Defense Logistics Agency awarded a delivery order valued at $5,680.22 to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 5 mg tablets (100 count) on August 8, 2025, with an ultimate completion date of August 11, 2025. This delivery order is structured as a firm fixed-price contract with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and...
- SPE2DB25D7068Indefinite Delivery Contract
- SPE2DB25D7068-SPE2DB26FTVAXDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Cetirizine HCL 10 mg tablets (300-count units) with a ceiling value of $1,500.09. This firm fixed-price delivery order is non-set-aside and scheduled for completion by November 3, 2025, with performance at the vendor's Conshohocken, Pennsylvania location. The award represents a routine pharmaceutical procurement supporting federal medical supply needs through DLA's distribution network. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems, supplying an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The company has demonstrated consistent capability to meet federal procurement requirements through competitive awards and maintains a strong position as a prime pharmaceutical vendor supporting Defense Health Agency and U.S. Coast Guard operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 10/31/25 |